SELLAS Life Sciences Group, Inc. Common Stock SLS
$15.46
+15.37%
at last close
Market Cap$3.12 billion
P/E Ratio—
Div Yield6.22%
Volume15.24M
52-Week Range
$1.39$15.88
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $10.00 (-35.3% downside)
Key Stats
- Today's Range
- $13.26 – $15.67
- 50-Day Range
- $7.07 – $15.88
- 52-Week Range
- $1.39 – $15.88
- Volume
- 15.24 million shs
- Average Volume
- 6.66 million shs
- Market Cap
- $3.12 billion
- P/E Ratio
- —
- Dividend Yield
- 6.22%
Dividend
- Dividend Yield
- 6.22%
- Annual Dividend
- $0.96
- Payout Ratio
- —
- Ex-Dividend Date
- 2011-03-24
Short Interest
- Short Interest
- 0.06%
- Days to Cover
- 2.01
About SELLAS Life Sciences Group, Inc. Common Stock
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Related Stocks
Compare head-to-head: SLS vs LLY·SLS vs JNJ·SLS vs ABBV·SLS vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.